Nicolas Lepareur

1.3k total citations
52 papers, 952 citations indexed

About

Nicolas Lepareur is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicolas Lepareur has authored 52 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Hepatology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicolas Lepareur's work include Radiopharmaceutical Chemistry and Applications (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Medical Imaging Techniques and Applications (11 papers). Nicolas Lepareur is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Medical Imaging Techniques and Applications (11 papers). Nicolas Lepareur collaborates with scholars based in France, Spain and Hungary. Nicolas Lepareur's co-authors include Nicolas Noiret, Étienne Garin, François Hindré, Emmanuel Garcion, Valérie Ardisson, Pascal Loyer, Mickaël Bourgeois, Franck Lacœuille, Jean‐Pierre Benoît and Éric Benoist and has published in prestigious journals such as PLoS ONE, Biomaterials and Chemical Communications.

In The Last Decade

Nicolas Lepareur

50 papers receiving 942 citations

Peers

Countries citing papers authored by Nicolas Lepareur

Since Specialization

Citations

This map shows the geographic impact of Nicolas Lepareur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Lepareur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Lepareur more than expected).

Fields of papers citing papers by Nicolas Lepareur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Lepareur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Lepareur. The network helps show where Nicolas Lepareur may publish in the future.

Co-authorship network of co-authors of Nicolas Lepareur

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Lepareur. A scholar is included among the top collaborators of Nicolas Lepareur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Lepareur. Nicolas Lepareur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	« Optimizing Imaging and Dose–Reponse in Radiotherapies » XVIe édition de l’atelier organisé par le réseau « Vectorisation, Imagerie, Radiothérapies » du Cancéropôle Grand-Ouest – 4–7 octobre 2023, Erquy, France 2025 ·Bulletin du Cancer ·(unknown), Vincent Potiron, Nicolas Lepareur, Latifa Rbah‐Vidal, Emmanuel Garcion, (unknown), Michel Chérel, Raphaël Tripier, Jacques Barbet	0
2	[^natY/⁹⁰Y]Yttrium and [^natLu/¹⁷⁷Lu]Lutetium Complexation by Rigid H₄OCTAPA Derivatives. Effect of Ligand Topology 2025 ·Chemistry - A European Journal ·(unknown), (unknown), (unknown), P. Pérez‐Lourido, David Esteban‐Gómez, Nicolas Lepareur, Gyula Tircsó, Carlos Platas‐Iglesias	2
3	An overview of current phase 3 radiopharmaceutical therapy clinical trials 2025 ·Frontiers in Medicine ·Nicolas Lepareur	1
4	Clinical Advances and Perspectives in Targeted Radionuclide Therapy 2023 ·Pharmaceutics ·Nicolas Lepareur, (unknown), Marie Mougin‐Degraef, Mickaël Bourgeois	29
5	188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study) 2023 ·Cancers ·Étienne Garin, Xavier Palard, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur, Valérie Ardisson, (unknown), Sophie Laffont, Boris Campillo‐Gimenez, Éric Bellissant, Julien Edeline	1
6	Tuning the lipophilic nature of pyclen-based 90Y3+ radiopharmaceuticals for β-radiotherapy 2021 ·Metallomics ·Mariane Le Fur, (unknown), Nicolas Lepareur, Olivier Rousseaux, Raphaël Tripier, Maryline Beyler	1
7	Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Julien Edeline, Yan Rolland, Nicolas Lepareur, Sophie Laffont, Xavier Palard, (unknown), Samuel Le Sourd, Marc Pracht, Valérie Ardisson, Nicolas Noiret, Éric Bellissant, Étienne Garin	16
8	Stable and Inert Yttrium(III) Complexes with Pyclen-Based Ligands Bearing Pendant Picolinate Arms: Toward New Pharmaceuticals for β-Radiotherapy 2018 ·Inorganic Chemistry ·Mariane Le Fur, Maryline Beyler, Enikő Molnár, (unknown), David Esteban‐Gómez, Gyula Tircsó, Carlos Platas‐Iglesias, Nicolas Lepareur, Olivier Rousseaux, Raphaël Tripier	31
9	Study of Binding Kinetics and Specificity of ^99mTc-SSS-Complex and ^99mTc-HMPAO to Blood Cells 2018 ·Contrast Media & Molecular Imaging ·(unknown), (unknown), Filippo Galli, Nicolas Lepareur, Anne Devillers, Alberto Signore	3
10	Cell Uptake and Biocompatibility of Nanoparticles Prepared from Poly(benzyl malate) (Co)polymers Obtained through Chemical and Enzymatic Polymerization in Human HepaRG Cells and Primary Macrophages 2018 ·Polymers ·(unknown), (unknown), (unknown), (unknown), C. Le Ribault, Sylvain Tranchimand, Caroline Nugier‐Chauvin, Éric Dubreucq, Pascal Loyer, Sandrine Cammas‐Marion, Nicolas Lepareur	8
11	The role of the capping bond effect on pyclen ^natY³⁺/⁹⁰Y³⁺ chelates: full control of the regiospecific N-functionalization makes the difference 2017 ·Chemical Communications ·Mariane Le Fur, Maryline Beyler, Enikő Molnár, (unknown), David Esteban‐Gómez, Gyula Tircsó, Carlos Platas‐Iglesias, Nicolas Lepareur, Olivier Rousseaux, Raphaël Tripier	28
12	Locoregional Confinement and Major Clinical Benefit of ¹⁸⁸Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma 2017 ·Theranostics ·(unknown), Igor Chourpa, (unknown), Audrey Griveau, (unknown), Sylvie Avril, Claire Legendre, Nicolas Lepareur, Didier Wion, François Hindré, François Davodeau, Emmanuel Garcion	51
13	Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides 2015 ·Frontiers in Medicine ·Nicolas Lepareur, (unknown), (unknown), (unknown), (unknown), (unknown), Nicolas Noiret, Sandrine Cammas‐Marion	5
14	Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma 2014 ·Applied Radiation and Isotopes ·Andrés López, Nicolas Noiret, Étienne Garin, Nicolas Lepareur	3
15	Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model 2011 ·PLoS ONE ·Claire Vanpouille‐Box, Franck Lacœuille, J. Roux, Christophe Aubé, Emmanuel Garcion, Nicolas Lepareur, Frédéric Oberti, (unknown), Nicolas Noiret, Étienne Garin, Jean‐Pierre Benoît, Olivier Couturier, François Hindré	35
16	Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with 188Re-lipid nanocapsules 2011 ·Biomaterials ·Claire Vanpouille‐Box, Franck Lacœuille, (unknown), Nicolas Lepareur, Laurent Lemaire, Jean-Jacques Lejeune, Jean‐Pierre Benoît, Philippe Meneï, Olivier Couturier, Emmanuel Garcion, François Hindré	60
17	Effect of Stabilized Iodized Oil Emulsion on Experimentally Induced Hepatocellular Carcinoma in Rats 2005 ·Journal of Vascular and Interventional Radiology ·Étienne Garin, Benoı̂t Denizot, J. Roux, Nicolas Noiret, Nicolas Lepareur, (unknown), (unknown), (unknown), (unknown), P. Bourguet, Jean‐Pierre Benoît, Jean-Jacques Lejeune	5
18	Syntheses and reactivity of ‘sulfur rich’ Re(iii) and Tc(iii) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 2005 ·Dalton Transactions ·Nicolas Lepareur, (unknown), Nicolas Noiret, Fiorenzo Refosco, Francesco Tisato, Marina Porchia, Giuliano Bandoli	16
19	Development and biodistribution of 188 Re-SSS lipiodol following injection into the hepatic artery of healthy pigs 2004 ·European Journal of Nuclear Medicine and Molecular Imaging ·Étienne Garin, Nicolas Noiret, Charles‐Henri Malbert, Nicolas Lepareur, Alain Roucoux, Sylvie Caulet-Maugendre, Annick Moisan, (unknown), J.Y. Herry, P. Bourguet	25
20	Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig 2004 ·Nuclear Medicine Communications ·Étienne Garin, Nicolas Noiret, Charles‐Henri Malbert, Nicolas Lepareur, Alain Roucoux, (unknown), Sylvie Caulet-Maugendre, Bruno Turlin, Annick Moisan, (unknown), (unknown), Éveline Boucher, Jean‐Luc Raoul, P. Bourguet	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact